The Endocannabinoid System Explained

On Sep 9, 2021

In this informative video, learn about your endocannabinoid system and the role it plays in your body.

Feel free to leave us a comment with any questions you have, or visit our website at MyriamsHemp.com.

Resources:
https://www.ncbi.nlm.nih.gov/pubmed/16224541
– Ahn K, et al. (2008). Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. DOI:
1021/cr0782067
– Alger BE. (2013). Getting high on the endocannabinoid system.
ncbi.nlm.nih.gov/pmc/articles/PMC3997295
– Background: Marijuana. (2007).
drugabuse.gov/publications/brain-power/grades-6-9/weeding-out-grass-module-4/background
– Cannabidiol (CBD) Pre-review report. (2017).
who.int/medicines/access/controlled-substances/5.2_CBD.pdf
– Cannabis and cannabinoids. (2019).
cancer.gov/about-cancer/treatment/cam/patient/cannabis-pdq?redirect=true
– Clinical endocannabinoid deficiency: Issue brief on clinical endocannabinoid deficiency. (2017).
health.state.mn.us/people/cannabis/docs/rulemaking/endocannabinoidbrief.pdf
-De Laurentiis A, et al. (2014). Role of the endocannabinoid system in the neuroendocrine responses to inflammation. DOI:
2174/1381612820666140130212957
– de Morais H, et al. (2016). Anandamide reverses depressive-like behavior, neurochemical abnormalities and oxidative-stress parameters in streptozotocin-diabetic rats: Role of CB1 receptors. DOI:
1016/j.euroneuro.2016.08.007
– Gomez M, et al. (2008). Cannabinoid signaling system.
ncbi.nlm.nih.gov/pmc/articles/PMC2633685
– Gorzkiewicz A, et al. (2018). Brain endocannabinoid signaling exhibits remarkable complexity. DOI:
1016/j.brainresbull.2018.06.012
– Human endocannabinoid system. (n.d.).
uclahealth.org/cannabis/human-endocannabinoid-system
– Lu H-C. (2015). An introduction to the endogenous cannabinoid system. DOI:
1016/j.biopsych.2015.07.028
– Maccarrone M, et al. (2015). Endocannabinoid signaling at the periphery: 50 years after THC. DOI:
1016/j.tips.2015.02.008
– Pacher P, et al. (2008). The endocannabinoid system as an emerging target of pharmacotherapy. DOI:
1124/pr.58.3.2
– Russo EB. (2016). Clinical endocannabinoid deficiency reconsidered: Current research supports the theory in migraine, fibromyalgia, irritable bowel, and other treatment-resistant syndromes. DOI:
1089/can.2016.0009
– Sharma P, et al. (2012). Chemistry, metabolism, and toxicology of cannabis: Clinical implications.
ncbi.nlm.nih.gov/pmc/articles/PMC3570572
– Smith SC, et al. (2014). Clinical endocannabinoid deficiency (CECD) revisited: Can this concept explain the therapeutic benefits of cannabis in migraine, fibromyalgia, irritable bowel syndrome and other treatment-resistant conditions?
ncbi.nlm.nih.gov/pubmed/24977967
– Zou S, et al. (2018). Cannabinoid receptors and the endocannabinoid system: Signaling and function in the central nervous system. DOI:
3390/ijms19030833

source